​

Viatris (VTRS) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

VTRS Stock Forecast

Viatris (VTRS) stock forecast, based on 7 Wall Street analysts, predicts a 12-month average price target of $13.75, with a high of $15.00 and a low of $12.00. This represents a 21.36% increase from the last price of $11.33.

$10 $11 $12 $13 $14 $15 High: $15 Avg: $13.75 Low: $12 Last Closed Price: $11.33

VTRS Stock Rating

Viatris stock's rating consensus is Hold, based on 7 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 1 Buy (14.29%), 5 Hold (71.43%), 1 Sell (14.29%), and 0 Strong Sell (0.00%).

Hold
Total 7 0 1 5 1 Strong Sell Sell Hold Buy Strong Buy

VTRS Forecast vs Benchmarks

TypeNameUpside
StockViatris21.36%
SectorHealthcare Stocks 25.20%
IndustrySpecialty & Generic Drug Manufacturers Stocks24.78%

Price Target Trends

1M3M12M
# Anlaysts--2
Avg Price Target--$14.00
Last Closing Price$11.33$11.33$11.33
Upside/Downside--23.57%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 25126-211
Dec, 24-26-210
Nov, 242262214
Oct, 242252213
Sep, 242252213
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jul 19, 2024Glen SantangeloJefferies$15.00$11.7727.44%32.39%
Mar 28, 2024David AmsellemPiper Sandler$13.00$11.839.89%14.74%
Jun 26, 2023David AmsellemPiper Sandler$10.00$9.841.63%-11.74%
Feb 01, 2023Barclays$15.00$12.1623.36%32.39%
Nov 09, 2022Ashwani VermaUBS$12.00$10.8310.80%5.91%
Jun 13, 2022Ashwani VermaUBS$9.00$10.77-16.43%-20.56%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Mar 28, 2024Piper SandlerNeutralNeutralhold
Jan 12, 2024Cowen & Co.Market Performdowngrade
Dec 27, 2023Morgan StanleyEqual-WeightEqual-Weighthold
Sep 27, 2023Wells FargoEqual-WeightEqual-Weighthold
Jun 26, 2023BMO CapitalPerformMarket Performdowngrade
Feb 17, 2023BMO CapitalMarket PerformPerformdowngrade
Feb 17, 2023BMO CapitalMarket Performdowngrade
Feb 01, 2023BarclaysOverweightOverweighthold
Nov 08, 2022Piper SandlerNeutralupgrade
Jun 13, 2022UBSSellinitialise

Financial Forecast

EPS Forecast

$-2 $-1 $0 $1 $2 $3 $4 $5 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-1.11$-1.05$1.71$0.05----
Avg Forecast$4.56$3.72$3.39$2.96$2.68$2.63$2.69$2.58
High Forecast$4.49$3.66$3.36$2.90$2.65$2.51$1.57$2.49
Low Forecast$4.68$3.81$3.42$3.00$2.71$2.75$3.70$2.63
Surprise %-124.34%-128.23%-49.56%-98.31%----

Revenue Forecast

$12B $13B $14B $16B $17B $19B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$11.95B$17.89B$16.26B$15.43B----
Avg Forecast$12.29B$17.89B$16.37B$15.47B$14.81B$14.29B$14.35B$16.56B
High Forecast$12.14B$17.67B$16.24B$15.42B$14.70B$13.95B$14.32B$16.13B
Low Forecast$12.52B$18.23B$16.45B$15.53B$14.86B$14.52B$14.38B$16.80B
Surprise %-2.78%-0.01%-0.67%-0.30%----

Net Income Forecast

$-2B $0 $2B $3B $5B $6B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-669.90M$-1.27B$2.08B$54.70M----
Avg Forecast$5.51B$-1.13B$66.99M$54.70M$3.24B$3.17B$3.18B$3.09B
High Forecast$5.42B$-1.47B$-175.56M$-143.36M$3.20B$3.02B$1.90B$3.01B
Low Forecast$5.64B$-795.14M$309.54M$252.76M$3.27B$3.32B$4.46B$3.17B
Surprise %-112.17%12.29%3002.87%-----

VTRS Forecast FAQ

Is Viatris stock a buy?

Viatris stock has a consensus rating of Hold, based on 7 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 1 Buy, 5 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Viatris is a neutral investment for most analysts.

What is Viatris's price target?

Viatris's price target, set by 7 Wall Street analysts, averages $13.75 over the next 12 months. The price target range spans from $12 at the low end to $15 at the high end, suggesting a potential 21.36% change from the previous close price of $11.33.

How does Viatris stock forecast compare to the average forecast of its sector, industry, and investment themes?

Viatris stock forecast shows a 21.36% upside, underperforming the average forecast for the healthcare stocks sector (25.20%) and underperforming the specialty & generic drug manufacturers stocks industry (24.78%).

What is the breakdown of analyst ratings for Viatris over the past three months?

  • January 2025: 9.09% Strong Buy, 18.18% Buy, 54.55% Hold, 0% Sell, 18.18% Strong Sell.
  • December 2024: 0% Strong Buy, 20.00% Buy, 60.00% Hold, 0% Sell, 20.00% Strong Sell.
  • November 2024: 14.29% Strong Buy, 14.29% Buy, 42.86% Hold, 14.29% Sell, 14.29% Strong Sell.

What is Viatris’s EPS forecast?

Viatris's average annual EPS forecast for its fiscal year ending in December is 2.68 for 2024, a 5260.00% increase from the reported $0.05 in 2023. The prediction for 2025 is $2.63, $2.69 for 2026, and $2.58 for 2027.

What is Viatris’s revenue forecast?

Viatris's average annual revenue forecast for its fiscal year ending in December is $14.81B for 2024, a -3.99% decrease from the reported $15.43B in 2023. The forecast for 2025 is $14.29B, $14.35B for 2026, and $16.56B for 2027.

What is Viatris’s net income forecast?

For its fiscal year ending in December, Viatris's average annual net income forecast is $3.24B for 2024, reflecting an 5819.59% increase from the reported $54.7M in 2023. The projection for 2025 is $3.17B, $3.18B for 2026, and $3.09B for 2027.